Diseases caused by altered specificity of a protein kinase for its allosteric activators

Philip Cohen (Lead / Corresponding author), Tom Snelling (Lead / Corresponding author)

Research output: Contribution to journalReview articlepeer-review

5 Downloads (Pure)

Abstract

Protein kinases regulate many intracellular processes, and their dysregulation causes cancers and other diseases. This review focuses on the atypical alpha-kinase 1 (ALPK1), which is activated in mammalian cells by nucleoside diphosphate heptoses (ADP-heptose, UDP-heptose, and CDP-heptose) produced by microbial pathogens but not by mammalian cells. Mutations in human ALPK1 cause ROSAH syndrome and spiradenoma, which result from an alteration in its specificity for nucleoside diphosphate heptoses, causing aberrant activation by mammalian nucleoside diphosphate sugars without microbial infection. These may be the first diseases caused by altered specificity of an enzyme for its allosteric activators and has suggested ways in which selective drugs could be developed to treat them without compromising the innate immune system.
Original languageEnglish
Pages (from-to)61-70
Number of pages10
JournalTrends in Biochemical Sciences
Volume50
Issue number1
DOIs
Publication statusPublished - 2 Jan 2025

Keywords

  • ALPK1
  • ROSAH
  • spiradenoma
  • protein kinase
  • allosteric activator
  • nucleotide sugar

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology

Fingerprint

Dive into the research topics of 'Diseases caused by altered specificity of a protein kinase for its allosteric activators'. Together they form a unique fingerprint.

Cite this